FXH vs. PBPH
FXH (First Trust Health Care AlphaDEX Fund) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - FXH tracks the StrataQuant Health Care Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. A 0.68 correlation means they provide meaningful diversification when combined. FXH charges 0.61%/yr vs 0.13%/yr for PBPH.
Performance
FXH vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FXH achieves a 0.68% return, which is significantly higher than PBPH's -1.13% return.
FXH
- 1D
- 1.48%
- 1M
- 1.65%
- YTD
- 0.68%
- 6M
- -0.88%
- 1Y
- 13.28%
- 3Y*
- 3.52%
- 5Y*
- 0.56%
- 10Y*
- 7.03%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
FXH vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
FXH First Trust Health Care AlphaDEX Fund | 0.68% | -3.57% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between FXH and PBPH is 0.68, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.68 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FXH vs. PBPH — Risk / Return Rank
FXH
PBPH
FXH vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Health Care AlphaDEX Fund (FXH) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FXH | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.15 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.09 | — | — |
| Martin ratioReturn relative to average drawdown | 3.33 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FXH | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.85 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.38 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | -0.04 | +0.56 |
Drawdowns
FXH vs. PBPH - Drawdown Comparison
The maximum FXH drawdown since its inception was -43.70%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for FXH and PBPH.
Loading charts...
Drawdown Indicators
| FXH | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.70% | -11.10% | -32.60% |
Max Drawdown (1Y)Largest decline over 1 year | -12.20% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -17.53% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -29.49% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -30.61% | — | — |
Current DrawdownCurrent decline from peak | -9.07% | -8.69% | -0.38% |
Average DrawdownAverage peak-to-trough decline | -9.46% | -4.23% | -5.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.99% | — | — |
Volatility
FXH vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| FXH | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.16% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 11.17% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 15.75% | 16.78% | -1.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.52% | 16.78% | -0.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.47% | 16.78% | +1.69% |
FXH vs. PBPH - Expense Ratio Comparison
FXH has a 0.61% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
FXH vs. PBPH - Dividend Comparison
FXH's dividend yield for the trailing twelve months is around 0.85%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
FXH First Trust Health Care AlphaDEX Fund | 0.85% | 0.75% | 0.41% | 0.24% | 0.20% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
FXH and PBPH have a correlation of 0.68, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.61% for FXH.
FXH has the higher dividend yield at 0.85%, compared with 0.09% for PBPH.
FXH tracks StrataQuant Health Care Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: First Trust and Portfolio Building Block. Their fees differ too: 0.61% for FXH and 0.13% for PBPH.
Find the right allocation for FXH and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer